Cigarette butts are the single greatest source of ocean trash
Greenbutts™ is an impact-driven company making the elimination of single-use micro-plastics possible with proprietary biomaterial technology. We have developed a patented, 100% biodegradable and water dispersing cigarette filter for use in the global tobacco industry and beyond.
The patented Greenbutts™ filter is designed to reduce the significant environmental impact caused by cigarette butts, over 6 trillion are discarded every year making a cigarette filter the most littered plastic in the world.
A viable alternative to acetate filters. We manufacture our filters from only the finest natural materials
Establishing partnerships with social impact organizations that keep our planet clean and healthy.
Help bring real change by supporting legislative proposals to mandate an end to cellulose acetate filters
A graduate of International Business and Finance from California State University at Long Beach (CSULB). Tadas worked in finance as a research analyst for the Norwegian investment company Baltic Management in Vilnius, Lithuania. He later became marketing manager of Omnitel Telecom and VP for Grey Worldwide Baltics Advertising agency. Upon his return to the USA in 2002 and building multiple small businesses in San Diego, California, Tadas co-founded Greenbutts™ in 2010 with the purpose to find a viable solution to the widespread pollution caused by cigarette filters.
CHIEF STRATEGY OFFICER
Senior Business Executive with more than 30 years of international, cross functional and cross-cultural experience, managing businesses and teams, supporting business growth and transformations across multiple geographies (Australasia, North and South America, East and Western Europe). Held several senior executive roles over his long-standing career within British American Tobacco (BAT) including the position of Group Head of Product Development in the United Kingdom, SVP Research & Development (R&D) in Reynolds American Inc. based in the USA and Vice President of KBP - Kentucky BioProcessing which is a world leader in developing and employing GMP processes to manufacture recombinant proteins using novel plant-based technology. Successfully led the development of novelty scientific knowledge and multi-category consumer lead product innovations.
CHIEF FINANCIAL OFFICER
Performance driven finance professional with 20+ years of experience as a CFO. Experience in closing go-public and M&A transactions for public companies and completing the resulting integration of the companies. Extensive technical and practical expertise in various industries covering implementing new operating systems and generating policies and procedures, treasury (corporate finance, capital management, risk and debt management) and financial accounting (IFRS implementation projects in leasing, insurance, and other financial services).
DIRECTOR OF BUSINESS DEVELOPMENT
Trained at University of Michigan in Biochemistry, previously Paulius was director of business development at Toronto based start-ups ACD/Labs and Pharma Algorithms in the digital chemistry/drug discovery space. He led key early relationships with clients such as Abbott, GSK, Pfizer. Big Data experience led him to co-found YC funded Infoharmoni, a real-time platform for visualization of Twitter. Joining Greenbutts™ in 2019, he manages R&D/production and key clients as well as relationships with global NGO's concerned with SUP and Ocean pollution.
DIRECTOR OF SALES
Jeff has worn many hats over the years from metal fabrication to machining, engineering, design and integration of making and packaging equipment for several industries. Jeff was co-founder and co-owner of Midwest tobacco Tube Inc. He build MTT from the ground up in 2007. At that time there were no cigarette tube factories left in the USA. Jeff sourced the equipment and set up the operations to create brands and in 2010 he obtained FDA approvals to become the premier tube company in the USA. Jeff joined Greenbutts™ as Director of Sales in 2020
DR. MIKE OGDEN
LEAD REGULATORY ADVISOR
Has joined as a Strategic Scientific Advisor. Dr. Mike Ogden comes to Greenbutts from a distinguished and accomplished 35+ career at Reynolds, a major multi-category U.S. tobacco and nicotine company, where he was responsible for all regulatory submissions, scientific research and scientific and regulatory advocacy and engagement for all Reynolds American tobacco operating companies and tobacco products. He recently retired from Reynolds as Senior Vice President of Scientific and Regulatory Affairs.
Is an exceptional sensory assessment expert with a 34 years craftsmanship & business leadership from farmer to consumer. In his recent role as Global Product Manager at British American Tobacco he managed key global drive brands as Dunhill and Pall Mall and he is internationally recognized as sensory "Guru".
With his passion about consumer experience, he brings to Greenbutts a vast experience in combustible & OTP which will enhance the Greenbutts product portfolio offers and global consumer proposition relevance.
VERA CHETTY PHD.
LEAD PROJECT SCIENTIST
Now Chief Scientist for NIRI, Vera attained a Masters Degree in Textile Engineering and PhD in Computer Simulation of Wetting and Wicking Phenomena at the Technical University of Liberec, Czech Republic. Vera has many years of experience in research and development of nonwoven and technical textiles which she gained by working for numerous research institutions in several different countries. Vera's main interest is in the development of novel nonwoven products.
Chief Restructuring Officer for PharmHouse Inc. and Muskoka Grown
Chief Financial Officer of Algonquin Income Fund Algonquin Power and Utilities Corp -TSX-AQN)
Chief Financial Officer of Mettrum Health Corp., that was acquired by Canopy Growth Corporation in early 2017 for $430 million Canadian Chartered Accountant (CPA, CA), a member of the Institute of Corporate Directors, ICD.D designation for directors Business graduate of Wilfred Laurier University
High Standard Capital was founded by Dan Kriznic as an M&A advisory firm specializing in venture companies with unique intellectual property. To date the firm has been involved in over $500 million in transactions with a strong focus on big tobacco.
More recently the firm sold Poda Holdings Inc, a publicly listed company, to Altria Group for $100.5 million USD and was instrumental in identifying the target, negotiating and closing the transaction. As part of the transaction, inventor and entrepreneur Ryan Selby, co-founder of PODA, joined the firm to assist in assessing unique intellectual property for the big tobacco space.